Total Funding
87
50
Total FundingSeed raised
Growth Score
-4 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
38567
Pioneering novel antibody-based cancer therapies informed by large-scale patient-derived biology.
- Tarek Ali Zaki: Co-Founder & CEOPast Role: Ando, Co-Founder & CFO
About the Company
OncoPrecision is a next-generation oncology therapeutics company leveraging large-scale, patient-derived biology and AI-enhanced discovery platforms to develop precision medicines with a higher probability of clinical success. The company integrates translational biology, machine learning, and modular ADC/BsAb engineering to build a pipeline
of first-in-class interventions across hematologic malignancies and solid tumors. The company is actively exploring strategic collaborations and partnerships to accelerate the development and commercialization of its programs.
